Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0000950170-25-102921 General Corporate
Debt relative to revenue 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
131.64% · OPTIONAL · VALID
Capex intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.61% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
26.98% · OPTIONAL · VALID
Revenue growth 15th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-9.15% · CORE · VALID
Inventory pressure 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
57.53% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
26.44% · CORE · VALID
Operating margin 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
18.09% · CORE · VALID
R&D intensity 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.63% · OPTIONAL · VALID
SBC intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.54% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 137.71%
Current 131.64%
Delta -6.08% Capex Intensity Decreased
Previous 7.69%
Current 6.61%
Delta -1.08% Cash Generation Increased
Previous 7.80%
Current 26.98%
Delta 19.18% Growth Decreased
Previous -8.15%
Current -9.15%
Delta -1.01% Inventory Pressure Decreased
Previous 57.80%
Current 57.53%
Delta -0.27% Margin Increased
Previous 25.75%
Current 26.44%
Delta 0.69% Profitability Increased
Previous 17.31%
Current 18.09%
Delta 0.79% R And D Intensity Increased
Previous 1.60%
Current 1.63%
Delta 0.02% Sbc Intensity Decreased
Previous 0.64%
Current 0.54%
Delta -0.10% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.